Bonnie Mohler
Adult Health · Canton, OHNPI 1972761278
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $233,861 of the $338,005 with a category attached, or 69.2%. It is spread thinly across 43 manufacturers, the largest accounting for just 18.6%. 2025 is the largest year on record at $115,745, 2.8 times the $40,815 reported in 2021. Among adult health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,817 payments — averaging $186.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$63K
- Phathom Pharmaceuticals, Inc.$60K
- Intercept Pharmaceuticals, Inc.$50K
- Evoke Pharma, Inc.$50K
- AbbVie$40K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$23K
- plus $52K from 37 others
What the payments were for
- Consulting fees$7,8582%
- Speaking & faculty fees$233,86169%
- Travel & lodging$60,41618%
- Food & beverage$35,60611%
- Education$2640%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$338,005 in reported general payments places this provider in the 95th percentile of 1,184 adult health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 52 | $385,710 |
| OcalivaObeticholic Acid | 19 | $235,819 |
| ZenpepLipase/Protease/Amylase | 32 | $147,666 |
| XifaxanRifaximin | 44 | $133,983 |
| LinzessLinaclotide | 153 | $125,657 |
| CreonLipase/Protease/Amylase | 28 | $103,968 |
| Dexlansoprazole DrDexlansoprazole | 354 | $83,724 |
| GimotiMetoclopramide Hcl | 33 | $66,915 |
| Mesalamine | 94 | $54,953 |
| IbsrelaTenapanor Hcl | 19 | $39,266 |
| MotegrityPrucalopride Succinate | 43 | $31,576 |
| VoqueznaVonoprazan Fumarate | 43 | $30,751 |
| Mesalamine ErMesalamine | 71 | $28,901 |
| TrulancePlecanatide | 32 | $21,628 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 300 | $20,123 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Intercept Pharmaceuticals, Inc.Ocaliva | $50,479 | $235,81919 claims |
| AbbVieLinzess, Creon | $40,018 | $229,625181 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance | $23,077 | $155,61076 claims |
| Aimmune Therapeutics, Inc.Zenpep | $454 | $147,66632 claims |
| Evoke Pharma, Inc.Gimoti | $49,887 | $66,91533 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity, Dexilant | $1,469 | $39,27256 claims |
| Ardelyx, Inc.Ibsrela | $5,402 | $39,26619 claims |
| Phathom Pharmaceuticals, Inc.Voquezna | $59,993 | $30,75143 claims |
| Redhill Biopharma Inc.Movantik | $339 | $18,14129 claims |
| Novo NordiskOzempic | $113 | $11,52313 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $487 | $9,16553 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,184 adult health providers in Ohio.
Other adult health in Canton
- Courtney Ray-MartyCanton$16K
- Kristen BurockCanton$8K
- Andrew GuinigundoCincinnati$215K
- Gabriella McCartyWestlake$177K
- Karen SteffeyLyndhurst$145K
- Marie ChambersCenterville$134K
- Susan FlickCleveland$131K
- Teresa ShafferBoardman$102K
- Jesse McClainYoungstown$79K
- Lucretia LongColumbus$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.